Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Glucocorticoids uncover a critical role for ASH2L on BCL-X expression regulation in leukemia cells.

Rocha-Viegas L, Silbermins M, Ogara MF, Pellegrini JM, Nuñez SY, García VE, Vicent GP, Pecci A.

Biochim Biophys Acta Gene Regul Mech. 2020 Jan;1863(1):194475. doi: 10.1016/j.bbagrm.2019.194475. Epub 2019 Dec 20.

PMID:
31870784
2.

The glucocorticoid receptor interferes with progesterone receptor-dependent genomic regulation in breast cancer cells.

Ogara MF, Rodríguez-Seguí SA, Marini M, Nacht AS, Stortz M, Levi V, Presman DM, Vicent GP, Pecci A.

Nucleic Acids Res. 2019 Nov 18;47(20):10645-10661. doi: 10.1093/nar/gkz857.

3.

C/EBPα mediates the growth inhibitory effect of progestins on breast cancer cells.

Nacht AS, Ferrari R, Zaurin R, Scabia V, Carbonell-Caballero J, Le Dily F, Quilez J, Leopoldi A, Brisken C, Beato M, Vicent GP.

EMBO J. 2019 Sep 16;38(18):e101426. doi: 10.15252/embj.2018101426. Epub 2019 Aug 2.

PMID:
31373033
4.

Hormone-control regions mediate steroid receptor-dependent genome organization.

Le Dily F, Vidal E, Cuartero Y, Quilez J, Nacht AS, Vicent GP, Carbonell-Caballero J, Sharma P, Villanueva-Cañas JL, Ferrari R, De Llobet LI, Verde G, Wright RHG, Beato M.

Genome Res. 2019 Jan;29(1):29-39. doi: 10.1101/gr.243824.118. Epub 2018 Dec 14.

5.

Steroid hormone receptors silence genes by a chromatin-targeted mechanism similar to those used for gene activation.

Nacht AS, Beato M, Vicent GP.

Transcription. 2017 Jan;8(1):15-20. doi: 10.1080/21541264.2016.1242456. Epub 2016 Oct 4.

6.

Hormone-induced repression of genes requires BRG1-mediated H1.2 deposition at target promoters.

Nacht AS, Pohl A, Zaurin R, Soronellas D, Quilez J, Sharma P, Wright RH, Beato M, Vicent GP.

EMBO J. 2016 Aug 15;35(16):1822-43. doi: 10.15252/embj.201593260. Epub 2016 Jul 7.

7.

ADP-ribose-derived nuclear ATP synthesis by NUDIX5 is required for chromatin remodeling.

Wright RH, Lioutas A, Le Dily F, Soronellas D, Pohl A, Bonet J, Nacht AS, Samino S, Font-Mateu J, Vicent GP, Wierer M, Trabado MA, Schelhorn C, Carolis C, Macias MJ, Yanes O, Oliva B, Beato M.

Science. 2016 Jun 3;352(6290):1221-5. doi: 10.1126/science.aad9335.

8.

Linker histones in hormonal gene regulation.

Vicent GP, Wright RH, Beato M.

Biochim Biophys Acta. 2016 Mar;1859(3):520-5. doi: 10.1016/j.bbagrm.2015.10.016. Epub 2015 Oct 27. Review.

PMID:
26518266
9.

Corrigendum: Relationship between nucleosome positioning and progesterone-induced alternative splicing in breast cancer cells.

Iannone C, Pohl A, Papasaikas P, Soronellas D, Vicent GP, Beato M, Valcárcel J.

RNA. 2015 Jul;21(7):1390. No abstract available.

10.

DNA damage and gene transcription: accident or necessity?

Beato M, Wright RH, Vicent GP.

Cell Res. 2015 Jul;25(7):769-70. doi: 10.1038/cr.2015.71. Epub 2015 Jun 9.

11.

The chromatin Remodeler CHD8 is required for activation of progesterone receptor-dependent enhancers.

Ceballos-Chávez M, Subtil-Rodríguez A, Giannopoulou EG, Soronellas D, Vázquez-Chávez E, Vicent GP, Elemento O, Beato M, Reyes JC.

PLoS Genet. 2015 Apr 20;11(4):e1005174. doi: 10.1371/journal.pgen.1005174. eCollection 2015 Apr.

12.

Relationship between nucleosome positioning and progesterone-induced alternative splicing in breast cancer cells.

Iannone C, Pohl A, Papasaikas P, Soronellas D, Vicent GP, Beato M, ValcáRcel J.

RNA. 2015 Mar;21(3):360-74. Erratum in: RNA. 2015 Jul;21(7):1390.

13.

Distinct structural transitions of chromatin topological domains correlate with coordinated hormone-induced gene regulation.

Le Dily F, Baù D, Pohl A, Vicent GP, Serra F, Soronellas D, Castellano G, Wright RH, Ballare C, Filion G, Marti-Renom MA, Beato M.

Genes Dev. 2014 Oct 1;28(19):2151-62. doi: 10.1101/gad.241422.114.

14.

Progesterone receptor interaction with chromatin.

Vicent GP, Nacht AS, Ballaré C, Zaurin R, Soronellas D, Beato M.

Methods Mol Biol. 2014;1204:1-14. doi: 10.1007/978-1-4939-1346-6_1.

PMID:
25182756
15.

The transcription factor GATA6 enables self-renewal of colon adenoma stem cells by repressing BMP gene expression.

Whissell G, Montagni E, Martinelli P, Hernando-Momblona X, Sevillano M, Jung P, Cortina C, Calon A, Abuli A, Castells A, Castellvi-Bel S, Nacht AS, Sancho E, Stephan-Otto Attolini C, Vicent GP, Real FX, Batlle E.

Nat Cell Biol. 2014 Jul;16(7):695-707. doi: 10.1038/ncb2992. Epub 2014 Jun 22.

PMID:
24952462
16.

C/EBPα poises B cells for rapid reprogramming into induced pluripotent stem cells.

Di Stefano B, Sardina JL, van Oevelen C, Collombet S, Kallin EM, Vicent GP, Lu J, Thieffry D, Beato M, Graf T.

Nature. 2014 Feb 13;506(7487):235-9. doi: 10.1038/nature12885. Epub 2013 Dec 15.

PMID:
24336202
17.

A new role for an old player: steroid receptor RNA Activator (SRA) represses hormone inducible genes.

Beato M, Vicent GP.

Transcription. 2013 Jul-Aug;4(4):167-71. Epub 2013 Jul 1.

18.

More help than hindrance: nucleosomes aid transcriptional regulation.

Ballaré C, Zaurin R, Vicent GP, Beato M.

Nucleus. 2013 May-Jun;4(3):189-94. doi: 10.4161/nucl.25108. Epub 2013 May 28. Review.

19.

Unliganded progesterone receptor-mediated targeting of an RNA-containing repressive complex silences a subset of hormone-inducible genes.

Vicent GP, Nacht AS, Zaurin R, Font-Mateu J, Soronellas D, Le Dily F, Reyes D, Beato M.

Genes Dev. 2013 May 15;27(10):1179-97. doi: 10.1101/gad.215293.113.

20.

Progesterone receptor induces bcl-x expression through intragenic binding sites favoring RNA polymerase II elongation.

Bertucci PY, Nacht AS, Alló M, Rocha-Viegas L, Ballaré C, Soronellas D, Castellano G, Zaurin R, Kornblihtt AR, Beato M, Vicent GP, Pecci A.

Nucleic Acids Res. 2013 Jul;41(12):6072-86. doi: 10.1093/nar/gkt327. Epub 2013 May 2.

21.

Nucleosome-driven transcription factor binding and gene regulation.

Ballaré C, Castellano G, Gaveglia L, Althammer S, González-Vallinas J, Eyras E, Le Dily F, Zaurin R, Soronellas D, Vicent GP, Beato M.

Mol Cell. 2013 Jan 10;49(1):67-79. doi: 10.1016/j.molcel.2012.10.019. Epub 2012 Nov 21.

22.

Impact of chromatin structure and dynamics on PR signaling. The initial steps in hormonal gene regulation.

Beato M, Vicent GP.

Mol Cell Endocrinol. 2012 Jun 24;357(1-2):37-42. doi: 10.1016/j.mce.2011.09.004. Epub 2011 Sep 12. Review.

PMID:
21945605
23.

When every minute counts: the enzymatic complexity associated with the activation of hormone-dependent genes.

Beato M, Vicent GP.

Cell Cycle. 2011 Aug 1;10(15):2407-9. Epub 2011 Aug 1. No abstract available.

PMID:
21670598
24.

Four enzymes cooperate to displace histone H1 during the first minute of hormonal gene activation.

Vicent GP, Nacht AS, Font-Mateu J, Castellano G, Gaveglia L, Ballaré C, Beato M.

Genes Dev. 2011 Apr 15;25(8):845-62. doi: 10.1101/gad.621811. Epub 2011 Mar 29.

25.

Minireview: role of kinases and chromatin remodeling in progesterone signaling to chromatin.

Vicent GP, Nacht AS, Zaurín R, Ballaré C, Clausell J, Beato M.

Mol Endocrinol. 2010 Nov;24(11):2088-98. doi: 10.1210/me.2010-0027. Epub 2010 May 19. Review.

26.

Erk signaling and chromatin remodeling in MMTV promoter activation by progestins.

Vicent GP, Zaurin R, Ballaré C, Nacht AS, Beato M.

Nucl Recept Signal. 2009 Oct 2;7:e008. doi: 10.1621/nrs.07008. Review.

27.

Nuclear factor 1 synergizes with progesterone receptor on the mouse mammary tumor virus promoter wrapped around a histone H3/H4 tetramer by facilitating access to the central hormone-responsive elements.

Vicent GP, Zaurin R, Nacht AS, Font-Mateu J, Le Dily F, Beato M.

J Biol Chem. 2010 Jan 22;285(4):2622-31. doi: 10.1074/jbc.M109.060848. Epub 2009 Nov 24.

28.

Two chromatin remodeling activities cooperate during activation of hormone responsive promoters.

Vicent GP, Zaurin R, Nacht AS, Li A, Font-Mateu J, Le Dily F, Vermeulen M, Mann M, Beato M.

PLoS Genet. 2009 Jul;5(7):e1000567. doi: 10.1371/journal.pgen.1000567. Epub 2009 Jul 17.

29.

Convergence on chromatin of non-genomic and genomic pathways of hormone signaling.

Vicent GP, Ballaré C, Nacht AS, Clausell J, Subtil-Rodríguez A, Quiles I, Jordan A, Beato M.

J Steroid Biochem Mol Biol. 2008 Apr;109(3-5):344-9. doi: 10.1016/j.jsbmb.2008.03.015. Epub 2008 Mar 13.

PMID:
18417338
30.
31.

Induction of progesterone target genes requires activation of Erk and Msk kinases and phosphorylation of histone H3.

Vicent GP, Ballaré C, Nacht AS, Clausell J, Subtil-Rodríguez A, Quiles I, Jordan A, Beato M.

Mol Cell. 2006 Nov 3;24(3):367-81.

32.

Progesterone signaling in breast and endometrium.

Ballaré C, Vallejo G, Vicent GP, Saragüeta P, Beato M.

J Steroid Biochem Mol Biol. 2006 Dec;102(1-5):2-10. Epub 2006 Oct 27.

PMID:
17070033
33.

Glucocorticoids repress bcl-X expression in lymphoid cells by recruiting STAT5B to the P4 promoter.

Rocha-Viegas L, Vicent GP, Barañao JL, Beato M, Pecci A.

J Biol Chem. 2006 Nov 10;281(45):33959-70. Epub 2006 Sep 7.

34.

DNA instructed displacement of histones H2A and H2B at an inducible promoter.

Vicent GP, Nacht AS, Smith CL, Peterson CL, Dimitrov S, Beato M.

Mol Cell. 2004 Nov 5;16(3):439-52.

35.

Steroid hormones induce bcl-X gene expression through direct activation of distal promoter P4.

Viegas LR, Vicent GP, Barañao JL, Beato M, Pecci A.

J Biol Chem. 2004 Mar 12;279(11):9831-9. Epub 2003 Dec 16.

36.

Complex role of histone H1 in transactivation of MMTV promoter chromatin by progesterone receptor.

Vicent GP, Koop R, Beato M.

J Steroid Biochem Mol Biol. 2002 Dec;83(1-5):15-23.

PMID:
12650697
37.
38.

Differences in nuclear retention characteristics of agonist-activated glucocorticoid receptor may determine specific responses.

Vicent GP, Pecci A, Ghini A, Piwien-Pilipuk G, Galigniana MD.

Exp Cell Res. 2002 Jun 10;276(2):142-54.

PMID:
12027445
39.

Mechanism of action of the potent sodium-retaining steroid 11, 19-oxidoprogesterone.

Galigniana MD, Vicent GP, Piwien-Pilipuk G, Burton G, Lantos CP.

Mol Pharmacol. 2000 Jul;58(1):58-70.

PMID:
10860927
40.

The promoter of the rat 3-hydroxy-3-methylglutaryl coenzyme A reductase gene contains a tissue-specific estrogen-responsive region.

Di Croce L, Vicent GP, Pecci A, Bruscalupi G, Trentalance A, Beato M.

Mol Endocrinol. 1999 Aug;13(8):1225-36.

PMID:
10446899
41.

The glucocorticoid properties of the synthetic steroid pregna-1,4-diene-11beta-ol-3,20-dione (deltaHOP) are not entirely correlated with the steroid binding to the glucocorticoid receptor.

Vicent GP, Pecci A, Ghini AA, Piwien-Pilipuk G, Veleiro AS, Burton G, Lantos CP, Galigniana MD.

Mol Cell Endocrinol. 1999 Mar 25;149(1-2):207-19.

PMID:
10375032
42.

Influence of calf serum on glucocorticoid-responses of certain progesterone derivatives.

Vicent GP, Burton G, Ghini A, Lantos CP, Galigniana MD.

J Steroid Biochem Mol Biol. 1998 Aug;66(4):211-6.

PMID:
9744518
43.

21-Hydroxy-6,19-oxidoprogesterone: a novel synthetic steroid with specific antiglucocorticoid properties in the rat.

Vicent GP, Monteserín MC, Veleiro AS, Burton G, Lantos CP, Galigniana MD.

Mol Pharmacol. 1997 Oct;52(4):749-53.

PMID:
9380039
44.

Features of the shuttle pair 11 beta-hydroxyprogesterone-11-ketoprogesterone.

Galigniana MD, Vicent GP, Burton G, Lantos CP.

Steroids. 1997 Apr;62(4):358-64.

PMID:
9090796

Supplemental Content

Loading ...
Support Center